Metacognitive accuracy differences in Parkinson’s disease and REM sleep behavioral disorder relative to healthy controls

Background: Metacognition is the ability to monitor and self-assess cognitive performance. It can be impaired in neurodegenerative diseases, with implications for daily function, and the ability of patients to reliably report their symptoms to health professionals. However, metacognition has not been systematically assessed in early-mid stage Parkinson’s disease (PD) and REM sleep behavioral disorder (RBD), a prodrome of PD. Objectives: This study aimed to evaluate metacognitive accuracy and self-confidence in PD and RBD patients across various cognitive tasks. Methods: We conducted detailed computerized cognitive assessments with 19 cognitive tasks within an established PD and RBD cohort. Participants self-rated their performance post-task. Metacognitive accuracy was calculated by comparing these ratings against objective performance and further analyzed against clinical and mental health factors. Results: PD and RBD patients’ metacognitive accuracy aligned with control subjects. However, they exhibited lower confidence across cognitive domains, reflecting their reduced cognitive performance. A notable inverse correlation was observed between their confidence and MDS-UPDRS I and II scales and HADS anxiety and depression scores. Conclusion: Our findings indicate that patients with early to mid-stage PD and RBD are generally aware of their cognitive status, differing from other neurological disorders. The inverse relationship between patient confidence and symptoms of depression, anxiety, and daily life challenges underscores the impact of emotional and functional difficulties on their self-perception of cognitive abilities. This insight could be significant for understanding how these conditions affect mental health, aiding clinicians in developing more effective patient care strategies

Dietary patterns and non-motor symptoms in Parkinson’s: A cross-sectional analysis

Objective: Evidence-based treatment for non-motor symptoms in Parkinson’s (PD) is limited. Lifestyle-based improvements including dietary changes may be a potential management strategy. To investigate the extent to which three dietary indices (Mediterranean-DASH Diet Intervention for Neurodegenerative Delay (MIND), Dietary Inflammation Index (DII), and Healthy Diet Indicator (HDI-2020) are associated with overall and individual non-motor symptom severity amongst individuals with Parkinson’s. Methods: An exploratory cross-sectional analysis of dietary (food frequency questionnaire) and clinical data, including measures of overall non-motor symptom severity, including fatigue, depression, anxiety, apathy, sleep problems, daytime sleepiness, and cognitive impairment.  The relationship between each dietary score and symptom outcome were assessed by linear regression for continuous variables and through general linear model analysis for tertiles of dietary adherence. Results: None of the dietary indices significantly predicted the total non-motor symptom severity score. The HDI predicted a significant decrease in fatigue scores as measured by the NeuroQol fatigue item (standardised β= - .19, p= .022), after adjusting for age, gender, energy intake, years diagnosed, physical activity level, education, and smoking. Self-reported depression symptoms reduced by .17 (standardised β) for each unit increase in HDI score (p= .035), after controlling for age, gender, energy intake and years diagnosed. No other significant associations were evident between dietary scores and any other non-motor symptoms. Conclusion: Our results indicate that fatigue and depression in Parkinson’s may be modified by diet; however more research is needed using a larger sample to replicate these findings

Online cognitive monitoring technology for people with Parkinson’s disease and REM sleep behavioural disorder

Automated online cognitive assessments are set to revolutionise clinical research and healthcare. However, their applicability for Parkinson’s Disease (PD) and REM Sleep Behavioural Disorder (RBD), a strong PD precursor, is underexplored. Here, we developed an online battery to measure early cognitive changes in PD and RBD. Evaluating 19 candidate tasks showed significant global accuracy deficits in PD (0.65 SD, p = 0.003) and RBD (0.45 SD, p = 0.027), driven by memory, language, attention and executive underperformance, and global reaction time deficits in PD (0.61 SD, p = 0.001). We identified a brief 20-min battery that had sensitivity to deficits across these cognitive domains while being robust to the device used. This battery was more sensitive to early-stage and prodromal deficits than the supervised neuropsychological scales. It also diverged from those scales, capturing additional cognitive factors sensitive to PD and RBD. This technology offers an economical and scalable method for assessing these populations that can complement standard supervised practices

Metacognitive accuracy differences in Parkinson's Disease and REM sleep behavioural disorder relative to healthy controls

Background: Metacognition is the ability to monitor and self-assess cognitive performance. It can be impaired in neurodegenerative diseases, with implications for daily function, and the ability of patients to reliably report their symptoms to health professionals. However, metacognition has not been systematically assessed in early-mid stage Parkinson’s disease (PD) and REM sleep behavioral disorder (RBD), a prodrome of PD. Objectives: This study aimed to evaluate metacognitive accuracy and self-confidence in PD and RBD patients across various cognitive tasks. Methods: We conducted detailed computerized cognitive assessments with 19 cognitive tasks within an established PD and RBD cohort. Participants self-rated their performance post-task. Metacognitive accuracy was calculated by comparing these ratings against objective performance and further analyzed against clinical and mental health factors. Results: PD and RBD patients’ metacognitive accuracy aligned with control subjects. However, they exhibited lower confidence across cognitive domains, reflecting their reduced cognitive performance. A notable inverse correlation was observed between their confidence and MDS-UPDRS I and II scales and HADS anxiety and depression scores. Conclusion: Our findings indicate that patients with early to mid-stage PD and RBD are generally aware of their cognitive status, differing from other neurological disorders. The inverse relationship between patient confidence and symptoms of depression, anxiety, and daily life challenges underscores the impact of emotional and functional difficulties on their self-perception of cognitive abilities. This insight could be significant for understanding how these conditions affect mental health, aiding clinicians in developing more effective patient care strategies

Einstein Aggregation Operators under Bipolar Neutrosophic Environment with Applications in Multi-Criteria Decision-Making

In this article, we introduce bipolar neutrosophic (BN) aggregation operators (AOs) as a revolutionary notion in aggregation operators (AOs) by applying Einstein operations to bipolar neutrosophic aggregation operators (AOs), with its application related to a real-life problem. The neutrosophic set is able to drawout the incomplete, inconsistent and indeterminate information pretty efficiently. Initially, we present essential definitions along with operations correlated to the neutrosophic set (NS) and its generalization, the bipolar neutrosophic set (BNS). The Einstein aggregation operators are our primary targets, such asthe BN Einstein weighted average (BNEWA), BN Einstein ordered weighted average (BNEOWA), BN Einstein hybrid average (BNEHA), BN Einstein weighted geometric (BNEWG), BN Einstein ordered weighted geometric (BNEOWG) and BN Einstein hybrid geometric (BNEHG), as well as their required properties. The most important benefit of using the suggested approaches is that they provide decision-makers with complete sight of the issue. These techniques, when compared to other methods, provide complete, progressive and precise findings. Lastly, by means of diverse types of newly introduced aggregation operators and a numerical illustration by an example, we suggest an innovative method to be used for multi-criteria community decision-making (DM). This illustrates the utility and applicability of this new strategy when facing real-world problems

Dyeing of cotton fabrics with reactive dyes and their physico-chemical properties

58-65The effect of dye concentration, electrolyte concentration, dyeing time and dyeing temperature on dyeing performance of cotton fabric dyed with reactive dyes, viz. Reactive Red 6B and Reactive Yellow RL, has been studied. The dye absorption increases with the increase in electrolyte concentration, dyeing time and dyeing temperature but decreases with the increase in dye concentration. Considering the effects of various external influences on the dyed cotton fabric, it has been observed that the Reactive Yellow RL imparts better physico-chemical properties than Reactive Red 6B in most cases

Online cognitive monitoring technology for people with Parkinson’s disease and REM sleep behavioural disorder

Automated online cognitive assessments are set to revolutionise clinical research and healthcare. However, their applicability for Parkinson’s Disease (PD) and REM Sleep Behavioural Disorder (RBD), a strong PD precursor, is underexplored. Here, we developed an online battery to measure early cognitive changes in PD and RBD. Evaluating 19 candidate tasks showed significant global accuracy deficits in PD (0.65 SD, p = 0.003) and RBD (0.45 SD, p = 0.027), driven by memory, language, attention and executive underperformance, and global reaction time deficits in PD (0.61 SD, p = 0.001). We identified a brief 20-min battery that had sensitivity to deficits across these cognitive domains while being robust to the device used. This battery was more sensitive to early-stage and prodromal deficits than the supervised neuropsychological scales. It also diverged from those scales, capturing additional cognitive factors sensitive to PD and RBD. This technology offers an economical and scalable method for assessing these populations that can complement standard supervised practices.</p

Online cognitive monitoring technology for people with Parkinson’s disease and REM sleep behavioural disorder

Automated online cognitive assessments are set to revolutionise clinical research and healthcare. However, their applicability for Parkinson’s Disease (PD) and REM Sleep Behavioural Disorder (RBD), a strong PD precursor, is underexplored. Here, we developed an online battery to measure early cognitive changes in PD and RBD. Evaluating 19 candidate tasks showed significant global accuracy deficits in PD (0.65 SD, p = 0.003) and RBD (0.45 SD, p = 0.027), driven by memory, language, attention and executive underperformance, and global reaction time deficits in PD (0.61 SD, p = 0.001). We identified a brief 20-min battery that had sensitivity to deficits across these cognitive domains while being robust to the device used. This battery was more sensitive to early-stage and prodromal deficits than the supervised neuropsychological scales. It also diverged from those scales, capturing additional cognitive factors sensitive to PD and RBD. This technology offers an economical and scalable method for assessing these populations that can complement standard supervised practices